Pacira BioSciences Reports Incentive Grants Under Nasdaq Listing Rule 5635(C)(4) Page 1

TAMPA, Fla., Sept. 09, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the granting of incentive awards on September 4, 2024 to 17 new employees under Pacira’s Amended and Restated 2014 Inducement Plan as a material incentive for each employee joining the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the Compensation Committee of the Board of Directors.

Two employees received stock options to purchase a total of 5,000 shares of Pacira stock and 17 employees received restricted stock units totaling 30,000 shares of Pacira stock.